Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) EPS (Basic) (2016 - 2025)

Corcept Therapeutics' EPS (Basic) history spans 10 years, with the latest figure at $0.24 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 17.24% year-over-year to $0.24; the TTM value through Dec 2025 reached $0.95, down 29.63%, while the annual FY2025 figure was $0.95, 29.63% down from the prior year.
  • EPS (Basic) for Q4 2025 was $0.24 at Corcept Therapeutics, up from $0.19 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.45 in Q3 2024 and bottomed at $0.15 in Q4 2022.
  • The 5-year median for EPS (Basic) is $0.26 (2021), against an average of $0.26.
  • The largest annual shift saw EPS (Basic) skyrocketed 100.0% in 2023 before it tumbled 57.78% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $0.28 in 2021, then crashed by 46.43% to $0.15 in 2022, then skyrocketed by 100.0% to $0.3 in 2023, then decreased by 3.33% to $0.29 in 2024, then decreased by 17.24% to $0.24 in 2025.
  • Per Business Quant, the three most recent readings for CORT's EPS (Basic) are $0.24 (Q4 2025), $0.19 (Q3 2025), and $0.33 (Q2 2025).